Veterinary Medicines

Bremervit AD3 E (300,000 I.U. + 100,000 I.U. + 50 mg)/ml ενέσιμο διάλυμα για ιπποειδή, βοοειδή, χοίρους, πρόβατα και αίγες.

Not authorised
  • TOCOPHERYL ACETATE
  • Colecalciferol
  • Retinol palmitate
Download as PDF

Product identification

Medicine name:
Bremervit AD3 E (300,000 I.U. + 100,000 I.U. + 50 mg)/ml ενέσιμο διάλυμα για ιπποειδή, βοοειδή, χοίρους, πρόβατα και αίγες.
Active substance:
  • TOCOPHERYL ACETATE
  • Colecalciferol
  • Retinol palmitate
Target species:
  • Horse
  • Cattle
  • Pig
  • Sheep
  • Goat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • TOCOPHERYL ACETATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol
    100000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Retinol palmitate
    300000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        259
        day
      • Milk
        120
        hour
    • Cattle
      • Meat and offal
        259
        day
      • Milk
        120
        hour
    • Pig
      • Meat and offal
        259
        day
    • Sheep
      • Meat and offal
        222
        day
      • Milk
        120
        hour
    • Goat
      • Meat and offal
        222
        day
      • Milk
        120
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • A. Nikolakopoulos S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bremer Pharma GmbH
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 37671/93/09-05-1994/K-0093701
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 29/01/2024
Download